Mohammad K. Khan, MD, PhD, MS, FACRO, FACR, DABR

One star
One star
One star
One star
One half star

Rating: 4.8 out of 5 (181 ratings)

Role

Radiation Oncology
Specialty

Lymphoma Myeloma and Plasma Cell Disorders Skin Cancer and Melanoma
Research Program

Cancer Immunology
Practicing Since

2010

Call 404-778-3473

Background

Board certified in radiobiology/physics by the American Board of Radiology, Mohammad Khan, MD, PhD, MS, FACRO, FACR, DABR, specializes in the treatment of lymphoma, leukemia, multiple myeloma, skin (melanoma, squamous cell, basal cell, merkel cell), and pediatric cancers. Dr. Khan serves as vice chair for education in the Department of Radiation Oncology where he works to complement and extend the department's educational efforts beyond its residency programs.

Dr. Khan fluently speaks English, Urdu, Hindi and is familiar with Spanish and Arabic.

Dr. Khan is a sought-after subject matter expert on low-dose radiotherapy and other radiation oncology topics. He has appeared on a number of media outlets, including CNN, Forbes, and WebMD.

Prior to medical school, Dr. Khan received two BS degrees, one in Nuclear Engineering and one in Biology with a minor in Biochemistry and Molecular Biology. Both degrees were awarded with Summa Cum Laude distinction. He then completed his MS, and PhD degrees in Nuclear Engineering with emphasis on health and medical physics from the University of Tennessee, Knoxville. His graduate research focused on the use of innovative imaging technologies, such as PET and MRI, to improve radiation treatment planning for emerging cancer therapeutics such as boron neutron capture therapy for patients with malignant brain tumors.

Dr. Khan did his residency training in radiation oncology at the Cleveland Clinic, Cleveland, OH. He completed a fellowship in ABS Prostate Bracytherapy at the Seattle Prostate Institute and an internship in medicine and surgery at the Cleveland Clinic.

Titles & Roles

Professor, Department of Radiation Oncology

Emory University School of Medicine
Vice Chair for Education, Department of Radiation Oncology

Emory University School of Medicine

Education & Training

Education

Residency, Radiation Oncology, 2011
Cleveland Clinic Foundation
Fellowship, 2010
Swedish Medical Center-Prostate Institute
Internship, Transitional, 2007
Cleveland Clinic Foundation
Medical Education, MD, 2006
University of Tennessee Memphis

Board Certifications

Radiation Oncology
American Board of Radiology, 2013

Professional Memberships

Dr. Khan is a fellow and member of the American College of Radiation Oncology. He also holds professional memberships with American College of Radiology, American Brachytherapy Society, American Society for Therapeutic Radiation Oncology and American Society of Clinical Oncology. He serves as a board member of the Georgia Radiological Society; is a vice chair of the Radiation Safety Committee for Human Use at Emory; and is an active member of the ACRIN/ECOG melanoma committee. He is also the Panel Chair for the leukemia/lymphoma section of the Radiation Oncology In-Training Examination (TXIT™) program at the American College of Radiology. He also serves on the radiation oncology exam committee of the American Board of Radiology where he is involved developing maintenance of certification exam questions, initial certification exam questions, and oral exam questions as they relate to the management of lymphoma, leukemia, and myeloma patients.

Research

Dr. Khan continues to be actively engaged in a wide variety of cancer related research, including designing new clinical trials, enrolling patients on existing trials, developing patient databases to look at treatment outcomes, and engineering new mathematical and physics solutions to improve existing technologies such as IMRT (Intensity Modulated Radiotherapy) and IGRT (Image Guided Radiotherapy).

View Current Clinical Trials


A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma Phase I Conditions Recurrent Squamous Cell Carcinoma Location Winship Cancer Institute
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-100M for the Treatment of Melanoma Brain Metastases Phase I Conditions Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma, Metastatic Mucosal Melanoma, Metastatic Ocular Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Location Winship Cancer Institute
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma Phase II Conditions Bone Pain, Metastatic Malignant Neoplasm in the Bone, Plasma Cell Myeloma Location Winship Cancer Institute

Publications

Dr. Khan has collectively authored numerous abstracts, manuscripts, commentaries and book chapters. He has presented at national and international conferences.

Title/Journal	Authors	Publication Date
Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlates. Nature communications	CS Jansen, MS Pagadala, MA Cardenas, RS Prabhu, S Goyal, C Zhou, P Chappa, BT Vo, C Ye, B Hopkins, J Zhong, A Klie, T Daniels, M Admassu, I Green, NT Pfister, SG Neill, JM Switchenko, N Prokhnevska, KB Hoang, MA Torres, S Logan, JJ Olson, EK Nduom, L Del Balzo, K Patel, SH Burri, AL Asher, S Wilkinson, R Lake, AH Kesarwala, KA Higgins, P Patel, V Dhere, AG Sowalsky, H Carter, MK Khan, H Kissick, ZS Buchwald	10/14/2024
Development of an artificial intelligence-based model to predict early recurrence of neuroendocrine liver metastasis after resection. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract	A Altaf, MM Munir, Y Endo, MMM Khan, Z Rashid, M Khalil, A Guglielmi, L Aldrighetti, TW Bauer, HP Marques, G Martel, V Lam, MJ Weiss, RC Fields, G Poultsides, SK Maithel, I Endo, TM Pawlik	08/26/2024
Pembrolizumab and low-dose, single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma: a prospective, single-centre, single-group, open-label, phase 2 pilot trial in the USA. The Lancet. Haematology	MK Khan, TH Nasti, JY Qian, TJ Kleber, JM Switchenko, JL Kaufman, AJ Nooka, MV Dhodapkar, ZS Buchwald, D Obiekwe, S Lonial, R Ahmed	07/01/2024
Total scalp irradiation: A study comparing multiple types of bolus and VMAT optimization techniques. Journal of applied clinical medical physics	TM Davis, K Luca, LJ Sudmeier, ZS Buchwald, MK Khan, X Yang, E Schreibmann, J Zhang, J Roper	04/01/2024
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis. Journal for immunotherapy of cancer	JS Patel, Y Woo, A Draper, CS Jansen, JW Carlisle, PF Innominato, FA Lévi, L Dhabaan, VA Master, MA Bilen, MK Khan, MC Lowe, H Kissick, ZS Buchwald, DC Qian	03/26/2024
Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node. Research square	Y Shen, E Connolly, M Aiello, C Zhou, P Chappa, H Song, P Tippitak, T Clark, M Cardenas, N Prokhnevska, A Mariniello, MS Pagadala, VR Dhere, S Rafiq, AH Kesarwala, A Orthwein, SN Thomas, MK Khan, J Brandon Dixon, GB Lesinski, MC Lowe, H Kissick, DS Yu, CM Paulos, NC Schmitt, ZS Buchwald	03/06/2024
SAMHD1 expression contributes to doxorubicin resistance and predicts survival outcomes in diffuse large B-cell lymphoma patients. NAR cancer	W Daddacha, D Monroe, AJ Schlafstein, AE Withers, EB Thompson, D Danelia, NC Luong, F Sesay, SK Rath, ER Usoro, ME Essien, AT Jung, JG Jiang, J Hu, B Mahboubi, A Williams, JE Steinbeck, X Yang, ZS Buchwald, WS Dynan, JM Switchenko, B Kim, MK Khan, DL Jaye, DS Yu	03/01/2024
Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRS. Research square	CS Jansen, RS Prabhu, MS Pagadala, P Chappa, S Goyal, C Zhou, SG Neill, N Prokhnevska, M Cardenas, KB Hoang, J Zhong, M Torres, S Logan, JJ Olson, EK Nduom, L Del Balzo, K Patel, SH Burri, AL Asher, S Wilkinson, R Lake, KA Higgins, P Patel, V Dhere, AG Sowalsky, MK Khan, H Kissick, ZS Buchwald	03/23/2023
Low-dose radiotherapy for COVID-19 pneumonia and cancer: summary of a recent symposium and future perspectives. International journal of radiation biology	MP Little, W Zhang, R van Dusen, N Hamada, M Bugden, M Cao, K Thomas, D Li, Y Wang, M Chandrashekhar, MK Khan, CN Coleman	01/01/2023
Clinical Presentation and Outcome Differences Between Black Patients and Patients of Other Races and Ethnicities With Mycosis Fungoides and Sézary Syndrome. JAMA dermatology	PB Allen, S Goyal, T Niyogusaba, C O'Leary, A Ayers, ES Tarabadkar, MK Khan, MJ Lechowicz	11/01/2022
Epidemiology beyond its limits. Science advances	LE McCullough, ML Maliniak, AB Amin, JM Baker, D Baliashvili, J Barberio, CM Barrera, CA Brown, LJ Collin, AA Freedman, DC Gibbs, MB Haddad, EW Hall, S Hamid, KRV Harrington, AM Holleman, JA Kaufman, MA Khan, K Labgold, VC Lee, AA Malik, LM Mann, KJ Marks, KN Nelson, ZS Quader, K Ross-Driscoll, S Sarkar, MP Shah, IY Shao, JP Smith, KK Stanhope, M Valenzuela-Lara, ME Van Dyke, KJ Vyas, TL Lash	06/10/2022
Clinical Correlation between Acute Exudative Polymorphous Paraneoplastic Vitelliform Maculopathy and Metastatic Melanoma Disease Activity: A 48-month Longitudinal Case Report. Ocular immunology and inflammation	CM Mueller, SL Hojjatie, DH Lawson, N Jain, J Robinson, MK Khan, ML Yushak, G A Datoo O'Keefe	02/17/2022
Whole-lung low-dose radiation therapy (LD-RT) for non-intubated oxygen-dependent patients with COVID-19-related pneumonia receiving dexamethasone and/or remdesevir. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology	CB Hess, TY Eng, TH Nasti, VR Dhere, TJ Kleber, JM Switchenko, BD Weinberg, N Rouphael, S Tian, S Rudra, LS Taverna, AP Daisson, R Ahmed, MK Khan	12/01/2021
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study. The Lancet. Oncology	DC Qian, T Kleber, B Brammer, KM Xu, JM Switchenko, JR Janopaul-Naylor, J Zhong, ML Yushak, RD Harvey, CM Paulos, DH Lawson, MK Khan, RR Kudchadkar, ZS Buchwald	12/01/2021
Biopsy, as Deauville May Deceive. International journal of radiation oncology, biology, physics	MK Khan, WF Mourad	11/01/2021
Racial differences in clinical presentation and outcomes in mycosis fungoides and Sézary syndrome in the United States: a large singe center retrospective analysis. European journal of cancer (Oxford, England : 1990)	PB Allen, S Goyal, C O'Leary, A Ayers, T Niyogusaba, MK Khan, MJ Lechowicz	10/01/2021
Improved Progression-Free Survival for Bulky and Non-Bulky Advanced Stage Diffuse Large B-Cell Lymphoma With Consolidative Radiation Therapy: A Bi-Institutional Analysis. Cureus	YA Syed, C Jiang, J Switchenko, K Kirmani, C Kelsey, MK Khan	08/01/2021
T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma. JAMA dermatology	JA Marks, JM Switchenko, DJ Martini, ES Tarabadkar, MK Khan, MJ Lechowicz, PB Allen	08/01/2021
Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related Pneumonia. International journal of radiation oncology, biology, physics	CB Hess, TH Nasti, VR Dhere, TJ Kleber, JM Switchenko, ZS Buchwald, WA Stokes, BD Weinberg, N Rouphael, JP Steinberg, KD Godette, DJ Murphy, R Ahmed, WJ Curran, MK Khan	03/15/2021
Melanoma Cell Intrinsic GABA_A Receptor Enhancement Potentiates Radiation and Immune Checkpoint Inhibitor Response by Promoting Direct and T Cell-Mediated Antitumor Activity. International journal of radiation oncology, biology, physics	DA Pomeranz Krummel, TH Nasti, M Kaluzova, L Kallay, D Bhattacharya, JC Melms, B Izar, M Xu, A Burnham, T Ahmed, G Li, D Lawson, J Kowalski, Y Cao, JM Switchenko, D Ionascu, JM Cook, M Medvedovic, A Jenkins, MK Khan, S Sengupta	03/15/2021
Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment. Cancers	S Tubin, MK Khan, S Gupta, B Jeremic	02/12/2021
Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases. Radiation oncology (London, England)	C Jiang, TJ Kleber, JM Switchenko, MK Khan	02/08/2021
A Call to Action: "Low-Dose Radiation May Help Cure COVID-19…" [Taps Mic] "…Is This Thing On?". JNCI cancer spectrum	MK Khan, CB Hess	02/01/2021
Virtual Away Rotations Increase Access to Radiation Oncology. Practical radiation oncology	J Janopaul-Naylor, D Qian, M Khan, S Brown, J Lin, Y Syed, A Schlafstein, N Ali, J Shelton, J Bradley, P Patel	01/01/2021
Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day 7 interim analysis of a registered clinical trial. Cancer	CB Hess, ZS Buchwald, W Stokes, TH Nasti, JM Switchenko, BD Weinberg, JP Steinberg, KD Godette, D Murphy, R Ahmed, WJ Curran, MK Khan	12/01/2020
Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with COVID-19-Related Pneumonia. International journal of radiation oncology, biology, physics	CB Hess, ZS Buchwald, WA Stokes, T Nasti, J Switchenko, BD Weinberg, N Rouphael, JP Steinberg, KD Godette, DJ Murphy, R Ahmed, WJ Curran, MK Khan	12/01/2020
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks? Radiation research	PG Prasanna, GE Woloschak, AL DiCarlo, JC Buchsbaum, D Schaue, A Chakravarti, FA Cucinotta, SC Formenti, C Guha, DJ Hu, MK Khan, DG Kirsch, S Krishnan, WW Leitner, B Marples, W McBride, MP Mehta, S Rafii, E Sharon, JM Sullivan, RR Weichselbaum, MM Ahmed, B Vikram, CN Coleman, KD Held	11/10/2020
Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet Therapy. Clinical lymphoma, myeloma & leukemia	MR Kudelka, JM Switchenko, MJ Lechowicz, N Esiashvili, CR Flowers, MK Khan, PB Allen	11/01/2020
Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy. Journal for immunotherapy of cancer	ZS Buchwald, TH Nasti, J Lee, CS Eberhardt, A Wieland, SJ Im, D Lawson, W Curran, R Ahmed, MK Khan	10/01/2020
Exosome-Containing Preparations From Postirradiated Mouse Melanoma Cells Delay Melanoma Growth In Vivo by a Natural Killer Cell-Dependent Mechanism. International journal of radiation oncology, biology, physics	KK Jella, TH Nasti, Z Li, DH Lawson, JM Switchenko, R Ahmed, WS Dynan, MK Khan	09/01/2020
Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain Metastases. International journal of radiation oncology, biology, physics	DA Pomeranz Krummel, TH Nasti, B Izar, RH Press, M Xu, L Lowder, L Kallay, M Rupji, H Rosen, J Su, W Curran, J Olson, B Weinberg, M Schniederjan, S Neill, D Lawson, J Kowalski, MK Khan, S Sengupta	09/01/2020
Changing Therapeutic Landscape for Melanoma With Multiple Brain Metastases. Neurosurgery	C Jiang, DG Wallington, CJ Anker, DH Lawson, ML Yushak, RR Kudchadkar, A Tarhini, MK Khan	09/01/2020
Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab. JAAD case reports	SA Westergaard, MJ Lechowicz, M Harrington, J Elsey, JL Arbiser, MK Khan	08/01/2020
The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches. Future oncology (London, England)	S Tubin, W Yan, WF Mourad, P Fossati, MK Khan	06/01/2020
Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia. Cancer	L Clough, AR Bayakly, KC Ward, MK Khan, SC Chen, MJ Lechowicz, CR Flowers, PB Allen, JM Switchenko	04/15/2020
Glioblastome Multiforme: A Bibliometric Analysis. World neurosurgery	M Akmal, N Hasnain, A Rehan, U Iqbal, S Hashmi, K Fatima, MZ Farooq, F Khosa, J Siddiqi, MK Khan	04/01/2020
Metastatic melanoma. CA: a cancer journal for clinicians	RR Kudchadkar, MC Lowe, MK Khan, SM McBrien	03/01/2020
Complete and Durable Response After Radiation Therapy to Primary Tumor Site of a Patient With Metastatic Anorectal Mucosal Melanoma With Oligoprogression on Nivolumab. Advances in radiation oncology	DG Wallington, AS Rashid, ZS Buchwald, LJ Sudmeier, MK Khan	01/01/2020
Retroperitoneal Follicular Dendritic Cell Sarcoma: A Case Report. Advances in radiation oncology	C Jiang, YA Syed, EB Burdette, DL Jaye, CR Flowers, MK Khan	01/01/2020
Spatially fractionated radiation therapy: History, present and the future. Clinical and translational radiation oncology	W Yan, MK Khan, X Wu, CB Simone, J Fan, E Gressen, X Zhang, CL Limoli, H Bahig, S Tubin, WF Mourad	01/01/2020
Immunomodulation Through Low-Dose Radiation for Severe COVID-19: Lessons From the Past and New Developments. Dose-response : a publication of International Hormesis Society	YN Hanekamp, J Giordano, JC Hanekamp, MK Khan, M Limper, CS Venema, SD Vergunst, JJC Verhoeff, EJ Calabrese	01/01/2020
Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironment. Radiation oncology (London, England)	S Tubin, MK Khan, G Salerno, WF Mourad, W Yan, B Jeremic	11/26/2019
Retrospective analysis of safety and efficacy of anti-PD-1 therapy and radiation therapy in advanced melanoma: A bi-institutional study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology	YM Mowery, K Patel, M Chowdhary, CN Rushing, K Roy Choudhury, JR Lowe, AC Olson, AJ Wisdom, JK Salama, BA Hanks, MK Khan, AKS Salama	09/01/2019
Radiotherapy Should Be Part of a Multidisciplinary Discussion for Most Patients With Lymphoma. Journal of oncology practice	MK Khan, C Jiang, K Subramanian	04/01/2019
Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities. Cancer journal (Sudbury, Mass.)	MK Khan, TH Nasti, ZS Buchwald, RR Weichselbaum, SJ Kron	01/01/2019
Neoadjuvant therapy of locally/regionally advanced melanoma. Therapeutic advances in medical oncology	A Khunger, ZS Buchwald, M Lowe, MK Khan, KA Delman, AA Tarhini	01/01/2019
The importance of surgery in scalp angiosarcomas. Surgical oncology	RJ Cassidy, JM Switchenko, ML Yushak, N Madden, MK Khan, DK Monson, JJ Beitler, JC Landry, KD Godette, TW Gillespie, KR Patel	12/01/2018
Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy. Vaccines	KK Jella, TH Nasti, Z Li, SR Malla, ZS Buchwald, MK Khan	09/26/2018
Myocarditis With Radiotherapy and Immunotherapy in Multiple Myeloma. Journal of oncology practice	A Chang, TH Nasti, MK Khan, S Parashar, JL Kaufman, LH Boise, S Lonial, R Ahmed, AK Nooka	09/01/2018
Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia. Leukemia & lymphoma	V Dhere, S Edelman, EK Waller, A Langston, M Graiser, EC Connolly, JM Switchenko, N Esiashvili, MK Khan	04/01/2018
Comparative outcomes and toxicities for ruthenium-106 versus palladium-103 in the treatment of choroidal melanoma. Melanoma research	H Danish, MJ Ferris, E Balagamwala, JM Switchenko, KR Patel, M Choudhary, C Craven, P Mendoza, J Suh, C Bergstrom, HE Grossniklaus, T M Aaberg, A Singh, IR Crocker, MK Khan	04/01/2018
High-resolution, ultrasound-guided, high-dose-rate, surface brachytherapy for basal cell carcinoma of the skin: A case report. Advances in radiation oncology	S Zhu, X Yang, KM Xu, JJ Jeong, MK Khan	01/01/2018
Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation. Frontiers in oncology	ZS Buchwald, J Wynne, TH Nasti, S Zhu, WF Mourad, W Yan, S Gupta, SN Khleif, MK Khan	01/01/2018
Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee. International journal of radiation oncology, biology, physics	YD Tseng, DJ Cutter, JP Plastaras, RR Parikh, O Cahlon, MD Chuong, K Dedeckova, MK Khan, SY Lin, LA McGee, EY Shen, SA Terezakis, SN Badiyan, YM Kirova, RT Hoppe, NP Mendenhall, M Pankuch, S Flampouri, U Ricardi, BS Hoppe	11/15/2017
Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases. American journal of clinical oncology	KR Patel, S Shoukat, DE Oliver, M Chowdhary, M Rizzo, DH Lawson, F Khosa, Y Liu, MK Khan	10/01/2017
Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement. International journal of radiation oncology, biology, physics	MJ Ferris, H Danish, JM Switchenko, C Deng, BA George, KC Goldsmith, KJ Wasilewski, WT Cash, MK Khan, BR Eaton, N Esiashvili	03/15/2017
4-1BB (CD137) and radiation therapy: A case report and literature review. Advances in radiation oncology	JC Shiao, N Bowers, TH Nasti, F Khosa, MK Khan	01/01/2017
Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndrome. Leukemia & lymphoma	HH Danish, S Liu, J Jhaveri, CR Flowers, MJ Lechowicz, N Esiashvili, MK Khan	12/01/2016
The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis. Melanoma research	HH Danish, KR Patel, JM Switchenko, TW Gillespie, J Jhaveri, M Chowdhary, M Abugideiri, KA Delman, DH Lawson, MK Khan	12/01/2016
The role of radiotherapy for patients over age 60 with diffuse large B-cell lymphoma in the rituximab era. Leukemia & lymphoma	RJ Cassidy, N Jegadeesh, J Switchenko, H Danish, N Esiashvili, CR Flowers, MK Khan	08/01/2016
BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis. Melanoma research	KR Patel, M Chowdhary, JM Switchenko, R Kudchadkar, DH Lawson, RJ Cassidy, RS Prabhu, MK Khan	08/01/2016
Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology	W Haque, B Dabaja, A Tann, M Khan, S Szeja, EB Butler, BS Teh	07/01/2016
CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation. Dermatology and therapy	HH Danish, TR Heumann, KT Bradley, J Switchenko, N Esiashvili, MJ Lechowicz, CR Flowers, MK Khan	06/01/2016
Changing Landscape of Radiotherapy for Melanoma Brain Metastases, in Light of Newer Targeted Agents and Immune Checkpoint Inhibitors. Journal of oncology practice	MK Khan, WJ Curran	06/01/2016
Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning. International journal of radiation oncology, biology, physics	M Abugideiri, RH Nanda, C Butker, C Zhang, S Kim, KY Chiang, E Butker, MK Khan, AE Haight, Z Chen, N Esiashvili	02/01/2016
Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma. Melanoma research	DE Oliver, KR Patel, J Switchenko, D Parker, DH Lawson, KA Delman, RR Kudchadkar, MK Khan	02/01/2016
First case of Merkel cell carcinoma in a young patient with Sweet syndrome. Advances in radiation oncology	A Liao, H Danish, B Stoff, MK Khan	01/01/2016
BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy. OncoTargets and therapy	M Chowdhary, KR Patel, HH Danish, DH Lawson, MK Khan	01/01/2016
Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases. Neuro-oncology	KR Patel, DH Lawson, RR Kudchadkar, BC Carthon, DE Oliver, D Okwan-Duodu, R Ahmed, MK Khan	10/01/2015
Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation. International journal of radiation oncology, biology, physics	N Jegadeesh, R Rajpara, N Esiashvili, Z Shi, Y Liu, D Okwan-Duodu, CR Flowers, MK Khan	05/01/2015
Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique. International journal of radiation oncology, biology, physics	TR Heumann, N Esiashvili, S Parker, JM Switchenko, A Dhabbaan, M Goodman, MJ Lechowicz, CR Flowers, MK Khan	05/01/2015
The emerging role of radiotherapy for desmoplastic melanoma and implications for future research. Melanoma research	DE Oliver, KR Patel, D Parker, KA Delman, DH Lawson, RR Kudchadkar, MK Khan	04/01/2015
Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanoma. American journal of clinical oncology	D Okwan-Duodu, BP Pollack, D Lawson, MK Khan	02/01/2015
Additional Support for Consolidative Radiotherapy for Diffuse Large B Cell Lymphoma in the Modern Rituximab Era. Acta haematologica	MK Khan, N Esiashvili, C Flowers	01/01/2015
Comparison of image-guided radiotherapy technologies for prostate cancer. American journal of clinical oncology	S Das, T Liu, AB Jani, P Rossi, J Shelton, Z Shi, MK Khan	12/01/2014
Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma. American journal of clinical oncology	DM Marcus, M Lowe, MK Khan, DH Lawson, IR Crocker, JW Shelton, A Melton, N Maynard, KA Delman, GW Carlson, M Rizzo	12/01/2014
The effects of androgen deprivation therapy on cardiac function and heart failure: implications for management of prostate cancer. Clinical genitourinary cancer	S Edelman, J Butler, BW Hershatter, MK Khan	12/01/2014
Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone. Journal of neuro-oncology	KR Patel, RS Prabhu, S Kandula, DE Oliver, S Kim, C Hadjipanayis, JJ Olson, N Oyesiku, WJ Curran, MK Khan, HK Shu, I Crocker	12/01/2014
Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia. International journal of radiation oncology, biology, physics	JL Mikell, EK Waller, JM Switchenko, S Rangaraju, Z Ali, M Graiser, WA Hall, AA Langston, N Esiashvili, HJ Khoury, MK Khan	06/01/2014
Cancerogenesis Risks between 64 and 320 Row Detector CT for Coronary CTA Screening. Journal of clinical imaging science	AN Khan, F Khosa, B Nikolic, W Shuaib, PJ Lin, MK Khan	01/01/2014
Absorbed radiation dose in radiosensitive organs using 64- and 320-row multidetector computed tomography: a comparative study. Scientifica	AN Khan, W Shuaib, B Nikolic, MK Khan, J Kang, F Khosa	01/01/2014
Respiratory-induced prostate motion using wavelet decomposition of the real-time electromagnetic tracking signal. International journal of radiation oncology, biology, physics	Y Lin, T Liu, X Yang, Y Wang, MK Khan	10/01/2013
The non-Gaussian nature of prostate motion based on real-time intrafraction tracking. International journal of radiation oncology, biology, physics	Y Lin, T Liu, W Yang, X Yang, MK Khan	10/01/2013
Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy. International journal of radiation oncology, biology, physics	Z Shi, S Das, D Okwan-Duodu, N Esiashvili, C Flowers, Z Chen, X Wang, K Jiang, LJ Nastoupil, MK Khan	07/01/2013
Clinically Significant Difference in Prostate Localization Using Daily Cone Beam CT (CBCT) and Electromagnetic Transponders. Practical radiation oncology	MK Khan, S Das, T Ogunleye, AB Jani, P Rossi, J Shelton, T Liu	01/01/2013
Dosimetric impact of intrafraction prostate motion using a new contour shifting method. Practical radiation oncology	MK Khan, S Shin, A Magnelli, P Xia	01/01/2013
Neurocognitive function and CNS integrity in adult survivors of childhood Hodgkin Lymphoma - a commentary on report from Krull and colleagues. Translational pediatrics	N Esiashvili, M Khan, C Flowers	01/01/2013
Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience. Radiation oncology (London, England)	MK Khan, SA Koyfman, GK Hunter, CA Reddy, JP Saxton	11/19/2012

Awards

Dr. Khan has received a number of awards and honors including the following:

Top Doctors “Best of Best” Award for multiple years of recognition, Atlanta Magazine, 2024
Educators Appreciation Award, Emory University School of Medicine, 2024
Innovations for Impact Award, Emory University School of Medicine, 2024
Department of Radiation Oncology Mentorship Award, Emory University School of Medicine, 2024
Department of Radiation Oncology Service Award, Emory University School of Medicine, 2024
Atlanta Magazine Top Doctors, 2021, 2022, 2023, 2024
Basic and Translational Sciences Research Award, ASTRO, 2023
Leadership and Service Award, GA-APPNA, 2023
Albert Nelson Marquis Lifetime Achievement Award by Marquis Who’s Who, 2021
Volunteer Service Award, ABR, 2020
Outstanding Mentorship Award, Winship Cancer Institute of Emory Unviersity, 2018
Top Doctors Award for Top Radiation Oncologist in Atlanta, 2017
Winship 5K Research Scholar Award, Winship Cancer Institute of Emory University, 2016
Top Doctor in Atlanta, International Association of Radiologists, 2014, 2016

During his residency training, he received several academic accolades including the Roentgen Resident/Fellow Research Award for Outstanding Radiological Research, the Scott Hamilton CARES Initiative Research Grant to fund a prospective phase I prostate cancer IGRT study, American College of Radiation Oncology Travel Award, American Brachytherapy Society Fellowship Award, and the American Society of Therapeutic Radiation Oncology Translation and Imaging Symposium Travel Award.

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.8	One star One star One star One star One half star	Provider showed concern
4.8	One star One star One star One star One half star	Provider explained things clearly
4.7	One star One star One star One star One half star	Provider discussed treatment options
4.8	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	09/29/2024	Wish I could get all my medical care from this team.
One star One star One star One star One star	09/18/2024	Everyone was great.
One star One star One star One star Empty star	06/07/2024	Expressed concern about me beginning chemo so soon after radiation. Suggested that my Doctors give me a least 2 weeks to rest and heal.
One star One star One star One star One star	04/25/2024	Very nice young man who was genuinely interested in me. Also connected us with a place to stay overnight during treatments.
One star One star One star One star One star	03/26/2024	Dr. Khan was very thorough in explaining treatment. Very patient, caring, listened to concerns and answered questions.
One star One star One star One star One star	03/23/2024	Dr Kahn demonstrated exceptional skill, empathy and expertise
One star One star One star One star One star	02/29/2024	He is the BEST!
One star One star One star One star One star	02/22/2024	Dr. Kahn is the best!!!
One star One star One star One star One star	01/26/2024	Dr Kahn was very thorough on his explanations to me regarding my condition and the path forward.
One star One star One star One star One star	01/11/2024	Dr. Khan is a professional and courteous physician.
One star One star One star One star One star	01/10/2024	Dr. Karen Godette along the other doctors and staff are the expert in their field. I always leave I formed and have 100% confidence in my current treatment plan and they all show such care and compassion when it comes to every patient that walks in the door.
One star One star One star One star One star	11/02/2023	Doctor Kahn and his assistants were very caring and made my wife and I feel confident about things to come.
One star One star One star One star One star	10/23/2023	Exemplary. Kind and informative. I am grateful.
One star One star One star One star One star	10/19/2023	Really liked Dr Khan. Feel very fortunate to have him treating my cancer.
One star One star One star One star One star	10/05/2023	I feel so very lucky to be able to get such good care. I can't gush enough. So grateful.
One star One star One star One star One star	10/01/2023	Dr Khan gave excellent explanation of the radiation treatments, the benefits and potential side effects.
One star One star One star One star One star	08/18/2023	I already have recommended
One star One star One star One star One star	08/17/2023	Dr Khan is very knowledgeable. He explained procedure in depth. Very informative appointment
One star One star One star One star One star	08/17/2023	Doctor was very informative and helpful in making my decisions.
One star One star One star One star One star	07/04/2023	Dr. Khan is an excellent physician who is caring and professional.